Delivery Order SPE2DB20D3304-SPE2DB24FW5Q8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of epinephrine 0.3 mg auto-injectors. The contract has a ceiling value of $1,495.30 and a period of performance through April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.60 firm fixed-price delivery order is for the supply of 4,567,781,870 Epinephrine 0.3 mg auto-injectors. The order has an ultimate completion date of April 3, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. This contract is part of a larger $999,999,999...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Epinephrine 0.3 mg auto-injectors. The contract, valued at $1,412.54, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) it holds with DLA with a potential value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of epinephrine 0.15 mg auto-injectors. The contract is valued at $10,190.63 and has a ceiling value of that amount. It is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Epinephrine 0.3 mg auto-injectors. The $8,251.89 contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order contract is issued under a larger $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,966,516 units of Epinephrine 0.15 mg auto-injectors. The contract has a ceiling value of $1,794.36 and a period of performance through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,881,870 epinephrine 0.3 mg auto-injectors. The contract has a potential value of $1,205.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The Delivery Order contract, valued at $1,814.54, has a firm fixed-price pricing type and an ultimate completion date of July 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Epinephrine 0.3 mg auto-injector devices. The contract has a ceiling value of $1,794.36 and is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. The contract was awarded on a full and open competition basis with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,592.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,727,625 units of Epinephrine 0.3 mg auto-injector 2-packs. The contract has a firm fixed price and an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), is the prime contractor with no set-aside designation...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB24FW5Q8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a ceiling value of $11,102.21 and a performance period through March 28, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger indefinite delivery contract (IDC) the company holds with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 3/27/24 |